Exact Sciences expects profitability in 2023, ahead of prior estimate


Madison-based cancer screening and diagnostic test maker Exact Sciences Corp. said Thursday it expects to turn profitable in the third quarter of 2023, ahead of its previous target of 2024.

Previous Centene showers politicians with millions as it courts contracts and settles overbilling allegations
Next Taste for Equity 2022: Meet two Portland chefs dishing up at this year's event